Skip to main content

Advertisement

Log in

Assessment of anti-GAD65-associated cerebellar ataxia with 18F-FDG cerebellar uptake: ROC analysis

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Anti-glutamic acid decarboxylase 65 (anti-GAD65)-associated neurological disorders include two major phenotypes, namely Stiff person syndrome (SPS) and cerebellar ataxia (CA). Considering the potential for better outcomes with prompt immunotherapy, early detection of CA is crucial. Hence, a non-invasive imaging biomarker to detect CA with high specificity is desired. Herein, we evaluated brain 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) PET in detecting CA based on cerebellar uptake using receiver operating characteristic (ROC) analysis and five-fold cross-validation.

Methods

This study was based on STARD 2015 guidelines: thirty patients with anti-GAD65-associated neurological disorders, 11 of whom with CA were studied. Five test sets were created after patients were randomly sorted and divided into 5 equal folds. Each iteration included 24 patients for ROC analysis and 6 patients reserved for testing. The Z scores of left cerebellum, vermis, right cerebellum, and the average of the three regions were used in ROC analysis to determine areas with significant area under the curve (AUC). The cut-off values with high specificity were determined among the 24 patients in each iteration and tested against the reserved 6 patients.

Results

Left cerebellum and average of the three regions showed significant AUC above 0.5 in all iterations with left cerebellum being the highest AUC in 4 iterations. Testing the cut-off values of the left cerebellum against the reserved 6 patients in each iteration showed 100% specificity with sensitivities ranging from 0 to 75%.

Conclusions

Cerebellar 18F-FDG PET uptake can differentiate CA phenotypes from patients with SPS with high specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data is provided as a supplementary file.

References

  1. Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol. 2013;9:1043–53.

    Article  CAS  PubMed  Google Scholar 

  2. Newsome SD. Other proven and putative autoimmune disorders of the CNS: Anti-GAD associated neurological disorders—Stiff-Person Syndrome, cerebellar ataxia, progressive encephalopathy with rigidity and myoclonus, and encephalitis. In: Neurobiology of Disease. 2 ed. New York: Oxford Academic; 2016.

  3. Shaw PJ. Stiff-man syndrome and its variants. Lancet. 1999;353:86–7.

    Article  CAS  PubMed  Google Scholar 

  4. Wang Y, Tourkevich R, Bosley J, Gold DR, Newsome SD. Ocular motor and vestibular characteristics of antiglutamic acid decarboxylase-associated neurologic disorders. J Neuroophthalmol. 2020. https://doi.org/10.1097/WNO.0000000000001084.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med. 2001;40:968–71.

    Article  CAS  PubMed  Google Scholar 

  6. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2007;78:187–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Raju R, Rakocevic G, Chen Z, Hoehn G, Semino-Mora C, Shi W, et al. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain. 2006;129:3270–6.

    Article  PubMed  Google Scholar 

  8. Folli F, Solimena M, Cofiell R, Austoni M, Tallini G, Fassetta G, et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med. 1993;328:546–51.

    Article  CAS  PubMed  Google Scholar 

  9. Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 2014;35:1038–46.

    Article  PubMed  Google Scholar 

  10. Hosoi Y, Suzuki-Sakao M, Terada T, Konishi T, Ouchi Y, Miyajima H, et al. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. J Neurol. 2013;260:3086–92.

    Article  CAS  PubMed  Google Scholar 

  11. Vale TC, Pedroso JL, Alquéres RA, Dutra LA, Barsottini OGP. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies. J Neurol Sci. 2015;359:21–3.

    Article  CAS  PubMed  Google Scholar 

  12. Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, et al. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021. https://doi.org/10.1136/jnnp-2020-325275.

    Article  PubMed  Google Scholar 

  13. Ariño H, Gresa-Arribas N, Blanco Y, Martínez-Hernández E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009–16.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders - insights and challenges. Nat Rev Neurol. 2020;16:353–65.

    Article  CAS  PubMed  Google Scholar 

  15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology. 2015;277:826–32.

    Article  PubMed  Google Scholar 

  16. Hadavi S, Noyce AJ, Leslie RD, Giovannoni G. Stiff person syndrome. Pract Neurol. 2011;11:272–82.

    Article  PubMed  Google Scholar 

  17. Chang T, Lang B. GAD antibodies in stiff-person syndrome. Neurology. 2004;63:1999–2000.

    Article  PubMed  Google Scholar 

  18. Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: from bench to bedside. Cerebellum Ataxias. 2017;4:16.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hammers A. Flumazenil positron emission tomography and other ligands for functional imaging. Neuroimaging Clin N Am. 2004;14:537–51.

    Article  PubMed  Google Scholar 

  20. Huang ZJ, Di Cristo G, Ango F. Development of GABA innervation in the cerebral and cerebellar cortices. Nat Rev Neurosci. 2007;8:673–86.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This publication was supported by the National Institute of Biomedical imaging and Bioengineering of the National Institutes of Health under award number T32EB006351.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lilja B. Solnes.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 172 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadaghiani, M.S., Roman, S., Wang, Y. et al. Assessment of anti-GAD65-associated cerebellar ataxia with 18F-FDG cerebellar uptake: ROC analysis. Ann Nucl Med 37, 528–534 (2023). https://doi.org/10.1007/s12149-023-01853-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-023-01853-w

Keywords

Navigation